Update: 18.06.2025
Last week: 23 week 2025 (02.06.2025 - 08.06.2025)
Last full month: May 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 180 | 2.7% | 14.0% | 1 | 21 050 379 | 3.2% | 10.6% | 0.8 | -4.9% |
| MoM | 40 295 | -3.4% | 13.1% | 0.5 | 92 162 664 | -1.7% | 9.9% | 0.5 | -7.3% |
| YTD | 211 044 | 27.2% | 12.9% | 1.8 | 463 207 525 | 25.7% | 9.6% | 0.2 | 9.5% |
| MAT | 466 566 | 26.4% | 13.1% | 3 | 933 831 409 | 20.5% | 9.4% | 0.8 | -2.1% |
| BRAINMAX | |||||||||
| WoW | 2 153 | -16.6% | 100.0% | 0 | 7 350 468 | -18.2% | 100.0% | 0 | -16.6% |
| MoM | 10 860 | -7.3% | 100.0% | 0 | 37 510 343 | -8.9% | 100.0% | 0 | -7.3% |
| YTD | 57 020 | 124.4% | 100.0% | 0 | 197 284 458 | 120.3% | 100.0% | 0 | 124.4% |
| MAT | 114 279 | 106.2% | 100.0% | 0 | 394 459 240 | 102.7% | 100.0% | 0 | 106.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 833 | 6.4% | 46.4% | 0.8 | 52 980 794 | 6.9% | 37.8% | 1.2 | 4.6% |
| MoM | 73 279 | 0.6% | 45.7% | 0.3 | 231 834 163 | -0.9% | 36.9% | -0.5 | 0.1% |
| YTD | 377 731 | -4.8% | 45.8% | 1.2 | 1 215 146 621 | -3.2% | 37.4% | 1 | -7.2% |
| MAT | 810 180 | -5.9% | 46.0% | 0.5 | 2 563 071 614 | -5.7% | 37.7% | -0.6 | -7.0% |
| MIGRENIUM | |||||||||
| WoW | 8 364 | 14.1% | 0.4% | 0 | 2 961 662 | 14.6% | 0.5% | 0 | 4.3% |
| MoM | 34 787 | 1.5% | 0.4% | 0 | 12 297 924 | 1.5% | 0.5% | 0 | -2.5% |
| YTD | 187 834 | -32.8% | 0.4% | -0.2 | 65 942 094 | -21.6% | 0.5% | -0.2 | 5.7% |
| MAT | 476 007 | -26.2% | 0.4% | -0.1 | 163 473 742 | 4.2% | 0.5% | 0 | 0.7% |
| MODELAX-N | |||||||||
| WoW | 31 652 | 38.9% | 23.9% | 6.6 | 17 145 658 | 35.0% | 17.3% | 4.5 | 0.6% |
| MoM | 107 892 | -5.5% | 17.9% | -0.8 | 60 208 046 | -1.4% | 13.3% | -0.4 | -1.0% |
| YTD | 660 285 | -6.1% | 20.0% | -3.3 | 349 183 298 | 17.9% | 14.4% | -0.4 | 9.5% |
| MAT | 1 420 820 | 2.6% | 20.2% | -0.6 | 712 392 802 | 35.4% | 14.0% | 1.6 | 5.6% |
| REDUXIN | |||||||||
| WoW | 11 117 | 3.4% | 30.6% | -0.3 | 59 936 878 | 1.5% | 42.7% | -0.9 | 4.6% |
| MoM | 49 047 | -2.8% | 30.6% | -0.9 | 269 646 984 | -1.1% | 42.9% | -0.7 | 0.1% |
| YTD | 259 875 | -11.7% | 31.5% | -1.6 | 1 416 243 435 | -11.1% | 43.6% | -2.6 | -7.2% |
| MAT | 561 044 | -8.5% | 31.9% | -0.5 | 2 986 018 961 | -4.8% | 43.9% | -0.3 | -7.0% |
| REDUXIN FORTE | |||||||||
| WoW | 3 757 | 5.7% | 10.3% | 0.1 | 16 542 316 | 1.8% | 11.8% | -0.2 | 4.6% |
| MoM | 16 876 | 7.1% | 10.5% | 0.7 | 78 994 217 | 10.6% | 12.6% | 1.2 | 0.1% |
| YTD | 82 744 | 7.2% | 10.0% | 1.4 | 376 534 446 | 12.0% | 11.6% | 1.8 | -7.2% |
| MAT | 172 936 | 2.2% | 9.8% | 0.9 | 761 969 926 | 6.9% | 11.2% | 1.2 | -7.0% |
| SALVISAR | |||||||||
| WoW | 9 860 | -5.4% | 1.3% | -0.1 | 5 267 879 | -1.1% | 1.4% | 0 | 1.1% |
| MoM | 50 675 | -7.6% | 1.5% | -0.2 | 26 072 693 | -6.4% | 1.5% | -0.2 | 4.2% |
| YTD | 295 943 | 20.4% | 1.8% | 0.3 | 146 460 644 | 50.2% | 1.7% | 0.4 | -3.4% |
| MAT | 621 929 | 23.4% | 1.6% | 0.4 | 289 897 823 | 57.7% | 1.5% | 0.5 | -6.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 211 044 | 27.2% | 12.9% | 1.8 | 463 207 525 | 25.7% | 9.6% | 0.2 | 9.5% |
| BRAINMAX | 57 020 | 124.4% | 100.0% | 0 | 197 284 458 | 120.3% | 100.0% | 0 | 124.4% |
| GOLDLINE PLUS | 377 731 | -4.8% | 45.8% | 1.2 | 1 215 146 621 | -3.2% | 37.4% | 1 | -7.2% |
| MIGRENIUM | 187 834 | -32.8% | 0.4% | -0.2 | 65 942 094 | -21.6% | 0.5% | -0.2 | 5.7% |
| MODELAX-N | 660 285 | -6.1% | 20.0% | -3.3 | 349 183 298 | 17.9% | 14.4% | -0.4 | 9.5% |
| REDUXIN CAPS | 259 875 | -11.7% | 31.5% | -1.6 | 1 416 243 435 | -11.1% | 43.6% | -2.6 | -7.2% |
| REDUXIN FORTE | 82 744 | 7.2% | 10.0% | 1.4 | 376 534 446 | 12.0% | 11.6% | 1.8 | -7.2% |
| SALVISAR | 295 943 | 20.4% | 1.8% | 0.3 | 146 460 644 | 50.2% | 1.7% | 0.4 | -3.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 466 566 | 26.4% | 13.1% | 3 | 933 831 409 | 20.5% | 9.4% | 0.8 | -2.1% |
| BRAINMAX | 114 279 | 106.2% | 100.0% | 0 | 394 459 240 | 102.7% | 100.0% | 0 | 106.2% |
| GOLDLINE PLUS | 810 180 | -5.9% | 46.0% | 0.5 | 2 563 071 614 | -5.7% | 37.7% | -0.6 | -7.0% |
| MIGRENIUM | 476 007 | -26.2% | 0.4% | -0.1 | 163 473 742 | 4.2% | 0.5% | 0 | 0.7% |
| MODELAX-N | 1 420 820 | 2.6% | 20.2% | -0.6 | 712 392 802 | 35.4% | 14.0% | 1.6 | 5.6% |
| REDUXIN CAPS | 561 044 | -8.5% | 31.9% | -0.5 | 2 986 018 961 | -4.8% | 43.9% | -0.3 | -7.0% |
| REDUXIN FORTE | 172 936 | 2.2% | 9.8% | 0.9 | 761 969 926 | 6.9% | 11.2% | 1.2 | -7.0% |
| SALVISAR | 621 929 | 23.4% | 1.6% | 0.4 | 289 897 823 | 57.7% | 1.5% | 0.5 | -6.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 180 | 2.7% | 14.0% | 1 | 21 050 379 | 3.2% | 10.6% | 0.8 | -4.9% |
| BRAINMAX | 2 153 | -16.6% | 100.0% | 0 | 7 350 468 | -18.2% | 100.0% | 0 | -16.6% |
| GOLDLINE PLUS | 16 833 | 6.4% | 46.4% | 0.8 | 52 980 794 | 6.9% | 37.8% | 1.2 | 4.6% |
| MIGRENIUM | 8 364 | 14.1% | 0.4% | 0 | 2 961 662 | 14.6% | 0.5% | 0 | 4.3% |
| MODELAX-N | 31 652 | 38.9% | 23.9% | 6.6 | 17 145 658 | 35.0% | 17.3% | 4.5 | 0.6% |
| REDUXIN CAPS | 11 117 | 3.4% | 30.6% | -0.3 | 59 936 878 | 1.5% | 42.7% | -0.9 | 4.6% |
| REDUXIN FORTE | 3 757 | 5.7% | 10.3% | 0.1 | 16 542 316 | 1.8% | 11.8% | -0.2 | 4.6% |
| SALVISAR | 9 860 | -5.4% | 1.3% | -0.1 | 5 267 879 | -1.1% | 1.4% | 0 | 1.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 40 295 | -3.4% | 13.1% | 0.5 | 92 162 664 | -1.7% | 9.9% | 0.5 | -7.3% |
| BRAINMAX | 10 860 | -7.3% | 100.0% | 0 | 37 510 343 | -8.9% | 100.0% | 0 | -7.3% |
| GOLDLINE PLUS | 73 279 | 0.6% | 45.7% | 0.3 | 231 834 163 | -0.9% | 36.9% | -0.5 | 0.1% |
| MIGRENIUM | 34 787 | 1.5% | 0.4% | 0 | 12 297 924 | 1.5% | 0.5% | 0 | -2.5% |
| MODELAX-N | 107 892 | -5.5% | 17.9% | -0.8 | 60 208 046 | -1.4% | 13.3% | -0.4 | -1.0% |
| REDUXIN CAPS | 49 047 | -2.8% | 30.6% | -0.9 | 269 646 984 | -1.1% | 42.9% | -0.7 | 0.1% |
| REDUXIN FORTE | 16 876 | 7.1% | 10.5% | 0.7 | 78 994 217 | 10.6% | 12.6% | 1.2 | 0.1% |
| SALVISAR | 50 675 | -7.6% | 1.5% | -0.2 | 26 072 693 | -6.4% | 1.5% | -0.2 | 4.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs